Yield10 Bioscience, Inc. is an agricultural bioscience company headquartered in Woburn, Massachusetts, that focuses on improving crop yield and performance through cutting-edge trait discovery and development. The company employs a proprietary platform to identify genes and pathways that control seed yield, oil content and abiotic stress tolerance. By leveraging tools such as gene editing, genomics and metabolic engineering, Yield10 aims to deliver step-change improvements in major row crops including canola, soybean, rice, wheat and corn.
A core element of Yield10’s research strategy is the use of Camelina sativa, a fast-growing oilseed crop, as a model system for trait evaluation. Camelina serves as a rapid testbed for candidate yield genes, allowing the company to advance promising traits more quickly than in larger grain crops. Once traits are validated in Camelina, Yield10 works to translate those improvements into high-value commercial crops through greenhouse and field trials under a range of environmental conditions. The company’s pipeline includes multiple trait development programs aimed at boosting pod number, seed size and seed oil content.
Yield10 supports its discovery and development efforts through collaborations and licensing agreements with leading agribusiness partners. These partnerships provide access to large-scale field trial capabilities and commercial germplasm, accelerating the path to market. Led by a management team of experienced professionals in agricultural biotechnology and crop science, Yield10 conducts research primarily in North America while pursuing global deployment of its technologies through strategic alliances with seed companies and other industry stakeholders.
AI Generated. May Contain Errors.
Free YTEN Stock Alerts